Related Experiment Video
Updated: Jun 2, 2026
09:41
Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures
Published on: March 20, 2019
N-acetylaspartylglutamate in CNS hypomyelination
M M C Wamelink1, E Struys, U Holwerda
1Department of Clinical Chemistry, Metabolic Unit, VU University Medical Center, Amsterdam, The Netherlands.
Neuropediatrics
|May 6, 2011
Summary
Cerebrospinal fluid N-acetylaspartylglutamate (NAAG) is not a reliable universal marker for hypomyelination. While elevated in some patients, it was normal in most, including those with diagnosed hypomyelinating disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- N-acetylaspartylglutamate (NAAG) is a neuropeptide found in the cerebrospinal fluid (CSF).
- Elevated CSF NAAG levels have been observed in certain hypomyelinating disorders, suggesting a potential role as a biomarker.
- Hypomyelinating disorders are a group of rare neurological conditions characterized by impaired myelin formation.
Purpose of the Study:
- To investigate whether CSF NAAG can serve as a diagnostic marker for hypomyelination.
- To determine if CSF NAAG levels can differentiate between various hypomyelinating disorders biochemically.
Main Methods:
- CSF samples were collected from a cohort of 28 patients with hypomyelination of various known and unknown causes.
- CSF NAAG concentrations were measured using biochemical assays.
Main Results:
- CSF NAAG levels were elevated in only 7 out of 28 patients with hypomyelination.
- The majority of patients, including those with diagnosed hypomyelinating disorders, exhibited normal CSF NAAG levels.
- No clear biochemical distinction between different hypomyelinating disorders was established based on CSF NAAG.
Conclusions:
- CSF NAAG is not a universal biomarker for hypomyelination.
- The underlying mechanisms responsible for elevated CSF NAAG in some individuals with hypomyelination remain unclear and require further investigation.
Related Concept Videos
01:25Nervous Tissue: Myelin
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...